Northeast Asia

Genertec Universal Medical Group, a Hong Kong-listed healthcare services company, has received strong response during syndication for its latest loan.

SCE Intelligent Commercial Management has raised HK$1.85bn ($238.3m) after pricing its IPO at the bottom of the guidance range.

Xpeng has kicked off its Hong Kong secondary listing, the first from a Chinese electric vehicle maker.

GLP China Holdings issued an offshore renminbi bond this week, raising Rmb1.2bn (Rmb185m) from the three year deal.

Shui On Land became the first Chinese corporate borrower to sell a sustainability-linked bond (SLB) this week — a move that worked to its advantage.

Chinese ride-hailing firm Didi Chuxing has launched its New York Stock Exchange IPO, aiming to raise $4.03bn from the largest China-into-US listing since Alibaba Group Holding’s jumbo $25bn deal in 2014.

Investors pumped more than $8bn in orders for Shenzhen Expressway Co's $300m capped bond on Thursday, with the Chinese issuer benefitting from its rarity value in the debt market and the stability of its business.

Three covered bonds issued this week from Korean Housing Finance Corp, Caffil and Oberbank were well received, but they would not have made it over the line without attractive new issue concessions.

Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO.

I have used Covid-19 as an excuse to avoid some unwanted social occasions over the last year or so, but a friend of mind has taken his Covid isolation to a new level.

Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.

Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.